Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?

Abstract

Ahmet Camtosun, Huseyin Celik, Battal Selcuk Cakmak, Cemal Tasdemir, Ramazan Altintas, Cemil Colak

Introduction and Hypothesis: We retrospectively evaluated the prognostic impact of neutrophil-lymphocyte ratio (NLR) as a marker for inflammatory and immune state in men with prostate cancer. Materials and Methods: This retrospective study was conducted in a single urology clinic to review the medical data of 558 patients who underwent transrectal prostate needle biopsies between 2007 and 2014. Prior to transrectal prostate needle biopsies, patient histories, physical examinations, and routine laboratory tests including blood biochemistry, urinaly-sis and urine cultures, free PSA and total PSA, rectal examination, transrectal ultrasound findings, and pathology results were evaluated.